Predictive Oncology
POAI
POAI
25 hedge funds and large institutions have $4.67M invested in Predictive Oncology in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
25
Holders Change
+13
Holders Change %
+108.33%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
6
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
1
Armistice Capital
New York
|
$2.48M |
| 2 |
2
Renaissance Technologies
New York
|
$718K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$670K |
| 4 |
4
Goldman Sachs
New York
|
$199K |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$168K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$5K |
| 3 |
MA
3
MCF Advisors
Covington,
Kentucky
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
US Bancorp
Minneapolis,
Minnesota
| $0 | 1 | – | – |
|
|
FWM
27
Focused Wealth Management
Newburgh,
New York
| $0 | 200 | – | – |
|